Results 101 to 110 of about 1,612 (126)
Some of the next articles are maybe not open access.

Total synthesis of the potent anti-inflammatory lipid mediator Protectin D1

Tetrahedron Letters, 2014
Abstract The total synthesis of the potent anti-inflammatory lipid mediator Protectin D1 derived from docosahexaenoic acid, has been achieved. The chiral hydroxy-groups at C10 and C17 were obtained via a chiral pool strategy from (4 R )-4-(2-hydroxyethyl)-2,2-dimethyl-1,3-dioxolane and 3,4- O -isopropylidene-2-deoxy- d -ribose, respectively.
Bernd W Spur, Ana R Rodríguez
exaly   +2 more sources

The Lipid Mediator Protectin D1 Inhibits Influenza Virus Replication and Improves Severe Influenza [PDF]

open access: yesCell, 2013
Influenza A viruses are a major cause of mortality. Given the potential for future lethal pandemics, effective drugs are needed for the treatment of severe influenza such as that caused by H5N1 viruses. Using mediator lipidomics and bioactive lipid screen, we report that the omega-3 polyunsaturated fatty acid (PUFA)-derived lipid mediator protectin D1 (
Jun Katahira, , Shota Nakamura
exaly   +3 more sources

Evaluation of IL-10, MCP-1, IFN gamma, and protectin D1 levels in patients with Hashimoto’s thyroiditis

Irish Journal of Medical Science, 2022
Hashimoto's thyroiditis (HT) is one of the most prevalent autoimmune endocrine diseases and caused by the loss of immune tolerance for the thyroid gland. Many pathophysiological mechanisms were speculated about the development of HT. In our study, we aimed to reveal the relationship between HT and IL-10, MCP-1, IFNɤ, and PD1 levels and compare them ...
Mehmet Erdogan   +2 more
exaly   +4 more sources

Protectin D1 decreases pancreatitis severity in mice by inhibiting neutrophil extracellular trap formation

International Immunopharmacology, 2021
Docosahexaenoic acid-derived protectin D1 (PD1) was identified critical in the resolution of inflammation in vivo, where it modulates the innate immune response and stimulates resolution. Acute pancreatitis (AP) is characterized by local pancreatic inflammation with mild forms whereas systemic inflammation with severe forms.
Zhiyang, Wu   +12 more
openaire   +2 more sources

Proresolving Lipid Mediators Resolvin D1 and Protectin D1 Isomer Attenuate Neointimal Hyperplasia in the Rat Carotid Artery Balloon Injury Model [PDF]

open access: yesJournal of Surgical Research, 2019
Specialized proresolving mediators from ω-3 polyunsaturated fatty acid may control resolution of inflammation. We evaluated the influence of two specialized proresolving mediators, resolvin D1 (RvD1) and protectin D1 isomer (PD1 iso) on neointimal hyperplasia after balloon injury.Sprague Dawley male rats at 12-14 wk of age were injured as a model of ...
Kota Yamamoto   +2 more
exaly   +3 more sources

Protectin D1 Alleviates Myocardial Ischemia/Reperfusion Injury by Regulating PI3K/AKT Signaling Pathway

Journal of Cardiovascular Translational Research, 2023
Myocardial ischemia/reperfusion (I/R) injury after the onset of acute myocardial infarction (AMI) can be life-threatening, and there is no effective strategy for therapeutic intervention. Here, we studied the potential of protectin D1 in protecting from I/R-induced cardiac damages and investigated the underlying mechanisms.
Peng Zhang   +5 more
openaire   +2 more sources

ChemInform Abstract: Stereoselective Synthesis of Protectin D1: A Potent Antiinflammatory and Proresolving Lipid Mediator.

ChemInform, 2014
AbstractThe UV and LC/MS‐MS data recorded on the synthetically prepared protectin D1 (I) match those of the endogenously produced material.
M. Aursnes   +4 more
openaire   +1 more source

Decreased plasma lipoxin A4, resolvin D1, protectin D1 are correlated with the complexity and prognosis of coronary heart disease: A retrospective cohort study

Prostaglandins & Other Lipid Mediators
This study aimed to assess the predictive capacity of specialized pro-resolving mediators (SPMs) regarding the complexity and prognosis of coronary heart disease (CHD). Total of 602 CHD patients were included in this study and categorized into low-risk, medium-risk, and high-risk groups based on the Synergy Between Percutaneous Coronary Intervention ...
Yun-Fei, Wang, Xue-Tao, Zhu, Ze-Ping, Hu
openaire   +2 more sources

Protectin D1 Improves Alveolar Barrier Breach After HCl-induced Acute Lung Injury

American Journal of Respiratory and Critical Care Medicine
Abstract Rationale: Acute respiratory distress syndrome (ARDS) is a clinical syndrome of diffuse pulmonary inflammation and pulmonary edema leading to severe acute respiratory failure. Despite a mortality rate of ARDS estimated to be 25-40%, there is still no effective pharmacological therapy for ARDS.
H. Irie   +4 more
openaire   +1 more source

Protectin D1 Is A Self-Produced Regulator Of Human Eosinophil Functions

C34. NEUTROPHILS, MAST CELLS, BASOPHILS AND EOSINOPHILS IN LUNG DISEASE, 2011
Jun Miyata   +8 more
openaire   +1 more source

Home - About - Disclaimer - Privacy